Comment submitted by James A. Losey, Counsel for GlaxoSmithKline (GSK)

Document ID: EPA-HQ-OAR-2007-0297-0031
Document Type: Public Submission
Agency: Environmental Protection Agency
Received Date: July 12 2007, at 05:07 PM Eastern Daylight Time
Date Posted: July 13 2007, at 12:00 AM Eastern Standard Time
Comment Start Date: June 12 2007, at 12:00 AM Eastern Standard Time
Comment Due Date: July 12 2007, at 11:59 PM Eastern Standard Time
Tracking Number: 80267a32
View Document:

This is comment on Proposed Rule

Protection of Stratospheric Ozone: Allocation of Essential Use Allowances for Calendar Year 2008

View Comment

Attached please find GlaxoSmithKline's Comments on the Allocation of Essential Use Allowances for Calendar Year 2008. Please contact James Losey, Esq. if you have any questions or concerns. Thank you.

Attachments:

Comment attachment submitted by James A. Losey, Counsel for GlaxoSmithKline (GSK)

Title:
Comment attachment submitted by James A. Losey, Counsel for GlaxoSmithKline (GSK)

View Attachment:

Related Comments

Total: 4

Comment submitted by B. Sachau
Public Submission Posted: 06/18/2007 ID: EPA-HQ-OAR-2007-0297-0030

Comment Period Closed
Jul 12,2007 11:59 PM ET

Comment submitted by James A. Losey, Counsel for GlaxoSmithKline (GSK)
Public Submission Posted: 07/13/2007 ID: EPA-HQ-OAR-2007-0297-0031

Comment Period Closed
Jul 12,2007 11:59 PM ET

Comment submitted by Marc Couturier, Senior Vice President, Global Business Development, Inyx, Inc.
Public Submission Posted: 07/16/2007 ID: EPA-HQ-OAR-2007-0297-0032

Comment Period Closed
Jul 12,2007 11:59 PM ET

Comment Submitted by Ronald J. Schott, Corporate Counsel, Environment, Safety and Health, Wyeth
Public Submission Posted: 06/04/2008 ID: EPA-HQ-OAR-2007-0297-0042

Comment Period Closed
Jul 12,2007 11:59 PM ET